These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 24344990

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Effect of lysophosphatidic acid increase the permeability of blood-brain barrier model].
    Gan N, Yin F, Peng J, Wang WD.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):416-8. PubMed ID: 18581898
    [Abstract] [Full Text] [Related]

  • 23. Methamphetamine reduces expressions of tight junction proteins, rearranges F-actin cytoskeleton and increases the blood brain barrier permeability via the RhoA/ROCK-dependent pathway.
    Xue Y, He JT, Zhang KK, Chen LJ, Wang Q, Xie XL.
    Biochem Biophys Res Commun; 2019 Feb 05; 509(2):395-401. PubMed ID: 30594393
    [Abstract] [Full Text] [Related]

  • 24. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
    Gu Y, Zheng G, Xu M, Li Y, Chen X, Zhu W, Tong Y, Chung SK, Liu KJ, Shen J.
    J Neurochem; 2012 Jan 05; 120(1):147-56. PubMed ID: 22007835
    [Abstract] [Full Text] [Related]

  • 25. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.
    Hawkins BT, Lundeen TF, Norwood KM, Brooks HL, Egleton RD.
    Diabetologia; 2007 Jan 05; 50(1):202-11. PubMed ID: 17143608
    [Abstract] [Full Text] [Related]

  • 26. [Critical roles of matrix metalloproteinases secreted by leukemic cells in the pathogenesis of central nervous system leukemia].
    Feng SR, Chen ZX, Cen JN, Shen HJ, Wang YY, Yao L.
    Zhonghua Xue Ye Xue Za Zhi; 2016 Dec 14; 37(12):1070-1076. PubMed ID: 28088972
    [Abstract] [Full Text] [Related]

  • 27. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability.
    Feng S, Zou L, Wang H, He R, Liu K, Zhu H.
    Molecules; 2018 Sep 17; 23(9):. PubMed ID: 30227623
    [Abstract] [Full Text] [Related]

  • 28. [Changes and regulatory mechanism of tight junction proteins in in vitro model of lead-induced blood-brain barrier injury].
    Xu Y, Che H, Liu M, Ke T, Ma Y, Chen J, Hao X.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov 17; 29(11):1141-6. PubMed ID: 24200059
    [Abstract] [Full Text] [Related]

  • 29. Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy.
    Haileselassie B, Joshi AU, Minhas PS, Mukherjee R, Andreasson KI, Mochly-Rosen D.
    J Neuroinflammation; 2020 Jan 27; 17(1):36. PubMed ID: 31987040
    [Abstract] [Full Text] [Related]

  • 30. Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9.
    Martins T, Baptista S, Gonçalves J, Leal E, Milhazes N, Borges F, Ribeiro CF, Quintela O, Lendoiro E, López-Rivadulla M, Ambrósio AF, Silva AP.
    Brain Res; 2011 Sep 09; 1411():28-40. PubMed ID: 21803344
    [Abstract] [Full Text] [Related]

  • 31. Matrix stiffness regulates the tight junction phenotypes and local barrier properties in tricellular regions in an iPSC-derived BBB model.
    Yan L, Dwiggins CW, Moriarty RA, Jung JW, Gupta U, Brandon KD, Stroka KM.
    Acta Biomater; 2023 Sep 01; 167():109-120. PubMed ID: 37302732
    [Abstract] [Full Text] [Related]

  • 32. Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy.
    Kikuchi DS, Campos ACP, Qu H, Forrester SJ, Pagano RL, Lassègue B, Sadikot RT, Griendling KK, Hernandes MS.
    J Neuroinflammation; 2019 Nov 28; 16(1):241. PubMed ID: 31779628
    [Abstract] [Full Text] [Related]

  • 33. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.
    Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA.
    J Cereb Blood Flow Metab; 2007 Apr 28; 27(4):697-709. PubMed ID: 16850029
    [Abstract] [Full Text] [Related]

  • 34. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
    Silwedel C, Förster C.
    J Neuroimmunol; 2006 Oct 28; 179(1-2):37-45. PubMed ID: 16884785
    [Abstract] [Full Text] [Related]

  • 35. Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport.
    Molino Y, Jabès F, Lacassagne E, Gaudin N, Khrestchatisky M.
    J Vis Exp; 2014 Jun 28; (88):e51278. PubMed ID: 24998179
    [Abstract] [Full Text] [Related]

  • 36. Impact of Wnt/β-catenin signaling on ethanol-induced changes in brain endothelial cell permeability.
    Laksitorini MD, Yathindranath V, Xiong W, Parkinson FE, Thliveris JA, Miller DW.
    J Neurochem; 2021 May 28; 157(4):1118-1137. PubMed ID: 32998179
    [Abstract] [Full Text] [Related]

  • 37. Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficient mouse brain.
    Beauchesne E, Desjardins P, Hazell AS, Butterworth RF.
    Neurochem Int; 2009 Sep 28; 55(5):275-81. PubMed ID: 19576514
    [Abstract] [Full Text] [Related]

  • 38. Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosis.
    D'Aversa TG, Eugenin EA, Lopez L, Berman JW.
    Neuropathol Appl Neurobiol; 2013 Apr 28; 39(3):270-83. PubMed ID: 22524708
    [Abstract] [Full Text] [Related]

  • 39. Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain.
    Al-Obaidi MMJ, Desa MNM.
    Cell Mol Neurobiol; 2018 Oct 28; 38(7):1349-1368. PubMed ID: 30117097
    [Abstract] [Full Text] [Related]

  • 40. The inhibitory effect of LPS on the expression of GPR81 lactate receptor in blood-brain barrier model in vitro.
    Boitsova EB, Morgun AV, Osipova ED, Pozhilenkova EA, Martinova GP, Frolova OV, Olovannikova RY, Tohidpour A, Gorina YV, Panina YA, Salmina AB.
    J Neuroinflammation; 2018 Jul 04; 15(1):196. PubMed ID: 29973231
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.